Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 21167353)

Published in Am Heart J on January 01, 2011

Authors

Seiichiro Matsuo1, Teiichi Yamane, Taro Date, Nicolas Lellouche, Ken-Ichi Tokutake, Mika Hioki, Keiichi Ito, Ryohsuke Narui, Shin-Ichi Tanigawa, Tokiko Nakane, Michifumi Tokuda, Seigo Yamashita, Yasuko Aramaki, Keiichi Inada, Kenri Shibayama, Satoru Miyanaga, Hiroshi Yoshida, Hidekazu Miyazaki, Kunihiko Abe, Ken-Ichi Sugimoto, Ikuo Taniguchi, Michihiro Yoshimura

Author Affiliations

1: Department of Cardiology, Jikei University School of Medicine, Tokyo, Japan. mattsuu@tc4.so-net.ne.jp

Articles by these authors

Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell (2007) 14.63

Retracted Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet (2007) 5.17

Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12

Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J Am Coll Cardiol (2009) 2.12

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06

Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer. Int J Urol (2010) 2.03

Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol (2002) 2.02

[Senile systemic amyloidosis: definition, diagnosis, why thinking about?]. Presse Med (2013) 2.00

Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res (2003) 2.00

Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98

Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One (2011) 1.98

Functional nature of electrogram fractionation demonstrated by left atrial high-density mapping. Circ Arrhythm Electrophysiol (2012) 1.90

Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol (2006) 1.84

Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J (2009) 1.80

Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol (2009) 1.74

A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol (2009) 1.72

Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol (2004) 1.71

Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet (2002) 1.66

Factors associated with diagnostic delay of oral squamous cell carcinoma. Oral Oncol (2003) 1.65

Mode and mechanisms of death after orthotopic heart transplantation. Heart Rhythm (2009) 1.60

Coronary spasm is associated with chronic low-grade inflammation. Circ J (2007) 1.58

The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest (2007) 1.57

Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm (2009) 1.56

General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc (2010) 1.51

Postmyocarditis ventricular tachycardia in patients with epicardial-only scar: a specific entity requiring a specific approach. J Cardiovasc Electrophysiol (2014) 1.50

Current status of catheter ablation for atrial fibrillation--updated summary of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF). Circ J (2014) 1.50

Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer. Int J Urol (2010) 1.49

Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J (2007) 1.47

The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica (2008) 1.46

Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem (2004) 1.44

Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm (2011) 1.44

Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol (2005) 1.43

Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization. Circ J (2015) 1.42

Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs. Circulation (2005) 1.40

Relation of high-pass filtered unipolar electrograms to bipolar electrograms during ventricular mapping. Pacing Clin Electrophysiol (2011) 1.39

Mapping of atrial tachycardias after catheter ablation for atrial fibrillation: use of bi-atrial activation patterns to facilitate recognition of origin. Heart Rhythm (2010) 1.39

Electrocardiographic left ventricular scar burden predicts clinical outcomes following infarct-related ventricular tachycardia ablation. Heart Rhythm (2013) 1.38

Parasystole due to re-entry as the possible mechanism of ventricular parasystole with second-degree entrance block. J Cardiovasc Med (Hagerstown) (2010) 1.37

Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 1.37

Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation (2002) 1.36

Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer (2002) 1.34

Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells. Mol Biol Cell (2009) 1.33

Prevalence, morphological and electrophysiological characteristics of confluent inferior pulmonary veins in patients with atrial fibrillation. Circ J (2008) 1.32

Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol (2003) 1.29

Coronary artery injury due to catheter ablation in adults: presentations and outcomes. Circulation (2009) 1.29

Reduction of AF recurrence after pulmonary vein isolation by eliminating ATP-induced transient venous re-conduction. J Cardiovasc Electrophysiol (2007) 1.27

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol (2004) 1.26

Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol (2007) 1.22

Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma. PLoS One (2011) 1.19

Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J (2006) 1.19

Septic endophthalmitis and meningitis associated with Klebsiella pneumoniae liver abscess. Hepatol Res (2002) 1.19

Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol (2011) 1.19

MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nippon Med Sch (2009) 1.18

Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun (2002) 1.18

Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus. Virology (2002) 1.17

CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging (2013) 1.17

Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol (2008) 1.16

Performance evaluation of salivary amylase activity monitor. Biosens Bioelectron (2004) 1.16

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol (2006) 1.15

Peri-mitral atrial flutter in patients with atrial fibrillation ablation. Heart Rhythm (2009) 1.13

Dynamic electrocardiographic changes due to cardiac compression by a giant hiatal hernia. Intern Med (2005) 1.12

Completion of mitral isthmus ablation using a steerable sheath: prospective randomized comparison with a nonsteerable sheath. J Cardiovasc Electrophysiol (2011) 1.11

Prevalence and clinical impact of QRS duration in patients with low-flow/low-gradient aortic stenosis due to left ventricular systolic dysfunction. Eur J Heart Fail (2014) 1.11

Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol (2007) 1.10

The underlying mechanisms for development of hypertension in the metabolic syndrome. Nutr J (2008) 1.10

Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol (2010) 1.10

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744). J Med Chem (2013) 1.09

Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation (2004) 1.09

Increased fatty acid synthase expression in prostate biopsy cores predicts higher Gleason score in radical prostatectomy specimen. BMC Clin Pathol (2014) 1.09

Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res (2003) 1.09

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Biochem Biophys Res Commun (2007) 1.08

Elevated fatty acid synthase expression in prostate needle biopsy cores predicts upgraded Gleason score in radical prostatectomy specimens. Prostate (2013) 1.08

Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus. Virology (2004) 1.07

Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies. Atherosclerosis (2011) 1.06

Ventricular tachycardia arising from the aortomitral continuity in structural heart disease: characteristics and therapeutic considerations for an anatomically challenging area of origin. Circ Arrhythm Electrophysiol (2009) 1.06

Tubulointerstitial nephritis associated with IgG4-related autoimmune disease. Am J Kidney Dis (2007) 1.06